0
Abstract: Slide Presentations |

SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE CURRENT ERA: VALIDATION OF THE NATIONAL INSTITUTE OF HEALTH (NIH) RISK STRATIFICATION EQUATION FREE TO VIEW

Thenappan Thenappan, MD*; Sanjiv J. Shah, MD; Stuart Rich, MD; Stephen L. Archer, MD; Mardi Gomberg-Maitland, MD, MSc
Author and Funding Information

Section of Cardiology, University of Chicago Hospitals, Chicago, IL


Chest


Chest. 2007;132(4_MeetingAbstracts):487a. doi:10.1378/chest.132.4_MeetingAbstracts.487a
Text Size: A A A
Published online

Abstract

PURPOSE: Background: Survival of patients with primary pulmonary hypertension (PPH) is based on the National Institute of Health (NIH) registry developed over 20 years ago at a time when there were no pulmonary artery hypertension (PAH)-specific therapies. Based on the results of the NIH registry, an equation that uses initial hemodynamic parameters (mean right atrial pressure, mean pulmonary artery pressure, and cardiac index) was developed and has since been used to estimate PAH survival. Hypothesis: The NIH survival equation is not predictive in the current era.

METHODS: We included patients (pts) with idiopathic or familial PAH (formerly PPH) referred to our center between 1982 and 2006. Vital statistics were collected by chart review and query of the Social Security Death Index. For patients on conventional therapy (diuretics, warfarin and digoxin) only at the time of referral, similar to the NIH registry, we compared rates of actual survival with predicted survival calculated using the NIH equation.

RESULTS: 276 pts were identified; the mean age at diagnosis was 45±14 years and 75% were female. At the time of referral, 36% were on warfarin, 44% were on diuretics, and 17% were on digoxin. 154/276 (56%) died on follow-up. For patients who were on conventional therapy alone at the time of referral (N=261), the median survival time was 5.3 (interquartile range 2.7 - 8.8) years, and the 1-, 3-, and 5-year actual survival rates were better than estimated survival calculated based on the NIH equation (Table).

CONCLUSION: The NIH equation is not an adequate predictor of survival in idiopathic or familial PAH patients in the current era.

CLINICAL IMPLICATIONS: New methods of risk prediction are necessary for patients with PAH.

DISCLOSURE: Thenappan Thenappan, None.

Tuesday, October 23, 2007

2:30 PM - 4:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543